The ENTA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ENTA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ENTA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ENTA Detailed Price Forecast - CNN Money||View ENTA Detailed Summary - Google Finance|
|View ENTA Detailed Summary - Yahoo! Finance||View ENTA Stock Research & Analysis - Zacks.com|
|View ENTA Trends & Analysis - Trade-Ideas||View ENTA Major Holders - Barrons|
|View ENTA Call Transcripts - NASDAQ||View ENTA Breaking News & Analysis - Seeking Alpha|
|View ENTA Annual Report - CompanySpotlight.com||View ENTA OTC Short Report - OTCShortReport.com|
|View ENTA Fundamentals - TradeKing||View ENTA SEC Filings - Bar Chart|
|View Historical Prices for ENTA - The WSJ||View Performance/Total Return for ENTA - Morningstar|
|View the Analyst Estimates for ENTA - MarketWatch||View the Earnings History for ENTA - CNBC|
|View the ENTA Earnings - StockMarketWatch||View ENTA Buy or Sell Recommendations - MacroAxis|
|View the ENTA Bullish Patterns - American Bulls||View ENTA Short Pain Metrics - ShortPainBot.com|
|View ENTA Stock Mentions - StockTwits||View ENTA Stock Mentions - PennyStockTweets|
|View ENTA Stock Mentions - Twitter||View ENTA Investment Forum News - Investor Hub|
|View ENTA Stock Mentions - Yahoo! Message Board||View ENTA Stock Mentions - Seeking Alpha|
|View Insider Transactions for ENTA - SECform4.com||View Insider Transactions for ENTA - Insider Cow|
|View ENTA Major Holdings Summary - CNBC||View Insider Disclosure for ENTA - OTC Markets|
|View Insider Transactions for ENTA - Yahoo! Finance||View Institutional Holdings for ENTA - NASDAQ|
|View ENTA Stock Insight & Charts - FinViz.com||View ENTA Investment Charts - StockCharts.com|
|View ENTA Stock Overview & Charts - BarChart||View ENTA User Generated Charts - Trading View|
Edited Transcript of ENTA earnings conference call or presentation 26-Nov-18 9:30pm GMT
Posted on Friday January 18, 2019
Q4 2018 Enanta Pharmaceuticals Inc Earnings Call
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Business Outlook for 2019 during the 37th Annual J.P. Morgan Healthcare Conference
Posted on Thursday January 03, 2019
Enanta Pharmaceuticals, Inc. (ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., Enanta’s President and Chief Executive Officer, will provide an update on its research and development programs in respiratory syncytial virus (RSV), hepatitis B virus (HBV) and non-alcoholic steatohepatitis (NASH)/primary biliary cholangitis (PBC), and discuss its business outlook for 2019 during Enanta’s presentation at the 37th Annual J.P. Morgan Healthcare Conference on January 7, 2019 at 4:30 p.m. Pacific time.
Enanta Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference
Posted on Thursday December 20, 2018
Enanta Pharmaceuticals, Inc. (ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., Enanta’s President and Chief Executive Officer will make a formal presentation at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 4:30 p.m. Pacific Time. The presentation will contain a business overview and an update on Enanta’s research and development programs.
Here is What Hedge Funds Think About Enanta Pharmaceuticals Inc (ENTA)
Posted on Saturday December 15, 2018
Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy league graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage […]